Form 4 for AEHR AEHR TEST SYSTEMS
Accepted 2023-01-26 00:00:00 ET · period of report 2023-01-24 · accession 0001654954-23-000874 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-26 | 2023-01-24 | AEHR | Erickson Gayn | Pres, CEO, Dir | S - Sale | $35.00 | -50.5K | 495.3K | -9% | -$1.77M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-24 | S | D | 50,496 | $35.00 | 495,253 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2022. (F2) The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. |